198 related articles for article (PubMed ID: 37527159)
1. Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1328-1337. PubMed ID: 37527159
[TBL] [Abstract][Full Text] [Related]
2. Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Clin Epigenetics; 2022 Jan; 14(1):14. PubMed ID: 35063012
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the role of immune cell composition in epigenetic age acceleration: Insights from cell-type deconvolution applied to human blood epigenetic clocks.
Zhang Z; Reynolds SR; Stolrow HG; Chen JQ; Christensen BC; Salas LA
Aging Cell; 2024 Mar; 23(3):e14071. PubMed ID: 38146185
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.
Koestler DC; Usset J; Christensen BC; Marsit CJ; Karagas MR; Kelsey KT; Wiencke JK
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):328-338. PubMed ID: 27965295
[No Abstract] [Full Text] [Related]
6. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.
Wiencke JK; Koestler DC; Salas LA; Wiemels JL; Roy RP; Hansen HM; Rice T; McCoy LS; Bracci PM; Molinaro AM; Kelsey KT; Wrensch MR; Christensen BC
Clin Epigenetics; 2017; 9():10. PubMed ID: 28184256
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.
Marsit CJ; Koestler DC; Christensen BC; Karagas MR; Houseman EA; Kelsey KT
J Clin Oncol; 2011 Mar; 29(9):1133-9. PubMed ID: 21343564
[TBL] [Abstract][Full Text] [Related]
8. Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Epigenomics; 2024 Jan; 16(1):41-56. PubMed ID: 38221889
[TBL] [Abstract][Full Text] [Related]
9. Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.
Gurung PMS; Barnett AR; Wilson JS; Hudson J; Ward DG; Messing EM; Bryan RT
Eur Urol Focus; 2020 Jul; 6(4):683-697. PubMed ID: 30803927
[TBL] [Abstract][Full Text] [Related]
10. RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
Yoon HY; Kim YJ; Kim JS; Kim YW; Kang HW; Kim WT; Yun SJ; Ryu KH; Lee SC; Kim WJ
Oncol Rep; 2016 Feb; 35(2):1195-203. PubMed ID: 26575865
[TBL] [Abstract][Full Text] [Related]
11. Assessment of immune cell profiles among post-menopausal women in the Women's Health Initiative using DNA methylation-based methods.
Nissen E; Reiner A; Liu S; Wallace RB; Molinaro AM; Salas LA; Christensen BC; Wiencke JK; Koestler DC; Kelsey KT
Clin Epigenetics; 2023 Apr; 15(1):69. PubMed ID: 37118842
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer.
Lin YL; Li ZG; He ZK; Guan TY; Ma JG
J Int Med Res; 2012; 40(6):2117-23. PubMed ID: 23321168
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
15. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
16. Semi-supervised recursively partitioned mixture models for identifying cancer subtypes.
Koestler DC; Marsit CJ; Christensen BC; Karagas MR; Bueno R; Sugarbaker DJ; Kelsey KT; Houseman EA
Bioinformatics; 2010 Oct; 26(20):2578-85. PubMed ID: 20834038
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
Galesloot TE; Grotenhuis AJ; Kolev D; Aben KK; Bryan RT; Catto JWF; Cheng KK; Conroy S; Dyrskjøt L; Fleshner NE; James ND; Lamy P; Lindskrog SV; Malats N; Mengual L; Verhaegh G; Zeegers MP; Kiemeney LALM; Vermeulen SH
Eur Urol Oncol; 2022 Feb; 5(1):70-83. PubMed ID: 34353775
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies.
Dugué PA; Bassett JK; Joo JE; Jung CH; Ming Wong E; Moreno-Betancur M; Schmidt D; Makalic E; Li S; Severi G; Hodge AM; Buchanan DD; English DR; Hopper JL; Southey MC; Giles GG; Milne RL
Int J Cancer; 2018 Apr; 142(8):1611-1619. PubMed ID: 29197076
[TBL] [Abstract][Full Text] [Related]
19. Association of Epigenetic Clock with Consensus Molecular Subtypes and Overall Survival of Colorectal Cancer.
Zheng C; Li L; Xu R
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1720-1724. PubMed ID: 31375479
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Gene Methylation and Clinical Factors in Non-Muscle-Invasive Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Xing Y; Xiong G; Fang D; Yang X; Li X; Zhou L
Clin Genitourin Cancer; 2016 Aug; 14(4):e371-8. PubMed ID: 27021587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
